STAT
DECEMBER 3, 2023
LONDON — The booming obesity market is attracting another player, as pharma giant Roche said Monday it was acquiring Carmot Therapeutics and the company’s line of weight loss drug candidates for $2.7 billion upfront. The deal for Carmot, which is based in Berkeley, Calif., includes additional milestone payments of up to $400 million.
Safe Biologics
DECEMBER 3, 2023
ASBM and GaBI Webinar Examines Policy Challenges to Interchangeable Biosimilars On November 30, ASBM and the Generics and Biosimilars Initiative (GaBI) hosted I nterchangeable Designation for Biosimilars- Ensuring Continuity of Patient Care: Upholding Interchangeability Status for Biosimilars. The webinar was the fourth in a series covering key health policy issues.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Med Ed 101
DECEMBER 3, 2023
Many institutions that pass medications need to be aware of when medications expire. The GLP-1 agonist class has been quickly expanding so we wanted to put together a storage chart to ensure that healthcare professionals and patients properly store their medications. In addition to the visual GLP-1 Agonist storage chart on this page, I’ve included […] The post GLP-1 Agonist Storage Chart – Free PDF appeared first on Med Ed 101.
FDA Law Blog: Biosimilars
DECEMBER 3, 2023
By Faraz Siddiqui & Alan M. Kirschenbaum — The Inflation Reduction Act (IRA) significantly changed the Part D benefit. As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”).
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Express Pharma
DECEMBER 3, 2023
Following the news that AbbVie has agreed to buy biotech ImmunoGen , the maker of the FDA-approved ovarian cancer treatment Elahere, for $10.1 billion; Israel Stern, Oncology & Hematology Analyst at GlobalData, a leading data and analytics company, offers his view: “The news comes one day after AbbVie announced that it is preparing to seek accelerated approval for its own antibody-drug conjugate (ADC) telisotuzumab-vedotin, which has shown promising response rates in advanced non-small cell
Drug Patent Watch
DECEMBER 3, 2023
This chart shows the drugs with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Spain? appeared first on DrugPatentWatch - Make Better Decisions.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmacy mentor
DECEMBER 3, 2023
Pharmacy Mentor and Tympa Health: Revolutionising Your Ear Health Services We are delighted to share exciting news about our recent collaboration with Tympa Health , a partnership that is set to reshape the landscape of earwax removal services in pharmacies. At Pharmacy Mentor, our commitment to advancing pharmacy services aligns seamlessly with Tympa Health’s cutting-edge approach to ear healthcare.
The Guardian - Pharmaceutical Industry
DECEMBER 3, 2023
Royal portraits | Viagra article | Losing sucks | Karlheinz Stockhausen | Hum improvement | Appalling apostrophes I’m confused. Is the £8m that Polly Toynbee reports is being spent by the government to send an “oak-framed portrait of the king” to every school going to encourage pupils to attend or have the reverse effect ( Too many pupils miss lessons, says Ofsted, and that’s right.
Pharma in Brief
DECEMBER 3, 2023
This year marks the 30-year anniversary of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ), introduced in 1993 to prevent patent infringement by linking the regulatory approval of generic or biosimilar drugs with the patent rights of innovators. Since their genesis, the Regulations have been the focal point of most of the pharmaceutical patent litigation in Canada.
Expert insights. Personalized for you.
346 
Let's personalize your content